Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of California, Los Angeles
With
eResearch Technology (eRT)
Age
40–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age \>40 years.
Clinical diagnosis of moderate to severe COPD in accordance with the definition of the American Thoracic Society (ATS).9
Smoking history \>10 pack-years.
Postbronchodilator FEV1/FVC\<70% and FEV1\<70% based on NHANES III reference values
Domestic situation felt to be supportive of remote health monitoring.
Ability to give informed consent.
You may not be if
Clinical diagnosis of asthma.
Pulmonary disease other than COPD (e.g., lung cancer, sarcoidosis, active tuberculosis, bronchiectasis, pulmonary fibrosis, cystic fibrosis, or alpha-1-antitrypsin deficiency) or had lung volume reduction.
Any other active disease that, in the opinion of the investigator, would put the safety of the subject at risk through study participation (e.g. unstable cardiovascular disease, renal failure, stroke).
Previously diagnosed cancer is considered a significant disease unless it is in complete remission for 2 years at the initial visit.
Any other disease that is life-threatening and carries a prognosis less than two years that, in the opinion of the investigator, is likely to influence the clinical course during the conduct of this trial.
Myocardial infarction within 6 weeks of enrolment.
Use of long-term oxygen therapy (LTOT) prescribed for greater than 12 hours a day.
A known or suspected history of drug or alcohol abuse within 2 years prior to the initial visit.
